Fusion Capital, LLC Abb Vie Inc. Transaction History

Fusion Capital, LLC

$224 Million
Q3 2024

A detailed history of Fusion Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fusion Capital, LLC holds 3,354 shares of ABBV stock, worth $580,309. This represents 0.3% of its overall portfolio holdings.

Number of Shares

3,354

Previous 3,333 0.63%

Holding current value

$580,309

Previous $571,000 15.94%

% of portfolio

0.3%

Previous 0.26%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $3,440 - $4,185	21 Added 0.63%	3,354 $662,000
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $13,931 - $16,268	-90 Reduced 2.63%	3,333 $571,000
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $5,753 - $6,555	-36 Reduced 1.04%	3,423 $623,000
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $37,702 - $42,461	-274 Reduced 7.34%	3,459 $536,000
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $13,626 - $15,774	-102 Reduced 2.66%	3,733 $556,000
Q2 2023 Aug 02, 2023	BUY	$132.51 - $164.9 $11,263 - $14,016	85 Added 2.27%	3,835 $516,000
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $4,482 - $5,162	31 Added 0.83%	3,750 $597,000
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $21,299 - $25,543	154 Added 4.32%	3,719 $601,000
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $6,576 - $7,542	-49 Reduced 1.36%	3,565 $479,000
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $1,651 - $2,099	-12 Reduced 0.33%	3,614 $554,000
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $4,487 - $5,567	34 Added 0.95%	3,626 $588,000
Q4 2021 Jan 12, 2022	BUY	$107.43 - $135.93 $21,486 - $27,186	200 Added 5.9%	3,592 $486,000
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $22,876 - $25,967	215 Added 6.77%	3,392 $366,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $10,100 - $11,252	96 Added 3.12%	3,177 $358,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $11,559 - $12,726	113 Added 3.81%	3,081 $333,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $11,107 - $14,996	138 Added 4.88%	2,968 $318,000
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $6,958 - $8,167	81 Added 2.95%	2,830 $248,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $201,694 - $269,896	2,749 New	2,749 $270,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fusion Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fusion Capital, LLC with notifications on news.

Account

Fusion Capital, LLC Abb Vie Inc. Transaction History